Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres ; volume:2 ; number:1 ; day:31 ; month:3 ; year:2014 ; pages:1-10 ; date:12.2014
Acta Neuropathologica Communications ; 2, Heft 1 (31.3.2014), 1-10, 12.2014
- Urheber
-
Ding, Dacheng
- Beteiligte Personen und Organisationen
-
Lim, Kah Suan
Eberhart, Charles G.
SpringerLink (Online service)
- DOI
-
10.1186/2051-5960-2-31
- URN
-
urn:nbn:de:1111-201608027508
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ding, Dacheng
- Lim, Kah Suan
- Eberhart, Charles G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Arsenic trioxide and (−)-gossypol synergistically target glioma stem-like cells via inhibition of hedgehog and notch signaling
Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway
PML-RARA mutations confer varying arsenic trioxide resistance
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
Arsenic trioxide and (−)-gossypol synergistically target glioma stem-like cells via inhibition of hedgehog and notch signaling
Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway
PML-RARA mutations confer varying arsenic trioxide resistance
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
Arsenic trioxide and (−)-gossypol synergistically target glioma stem-like cells via inhibition of hedgehog and notch signaling
Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway
PML-RARA mutations confer varying arsenic trioxide resistance
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide